Skip to Main Content
Alcohol Addiction | Mental Health & Behavioral Research, Phase Pilot

Does Propanolol, a Beta Blocker, Attenuate Stress-Induced Drinking?

What is the purpose of this trial?

For this protocol, the investigators plan to conduct a pilot study evaluating the effect of propranolol on alcohol consumption. Using a parallel design, the investigators plan to randomize 20 non-treatment seeking adults with alcohol use disorders (DSM-5) to propranolol extended release (160mg/day or placebo; n=10 per cell) to evaluate whether propranolol reduces alcohol self-administered in the laboratory. Importantly, the investigators will evaluate whether propranolol counteracts stress-induced effects on alcohol self-administration. Following titration to steady state medication levels over a 2-week period, each subject will complete two laboratory sessions consisting of a well validated method for inducing stress or neutral/relaxing state (order counterbalanced), followed by a 2-hour alcohol self-administration paradigm known to be sensitive to medication effects.

  • Trial with
    National Institute on Alcohol Abuse and Alcoholism (NIAAA)
  • Ages
    21 years - 65 years
  • Gender
    Both

Contact Information

For more information about this study, including how to volunteer, contact Meaghan Lavery

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

  • Last Updated
    02/02/2024
  • Study HIC
    #2000022090